Attention Deficits in a Comorbidity-Free Sample of Euthymic Pediatric Bipolar Disorder

Nandini Banerjee1, Shi-Kai Liu2, Vinod K Sinha1

  • 1Central Institute of Psychiatry, Ranchi, India.

Insights

Pediatric bipolar disorder (PBD) patients without comorbidities show significant attention deficits. These findings support attention deficits as a key endophenotypic marker for bipolar disorder (BD) across age groups.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Genetics

Background:

  • Attention deficits are potential endophenotypic markers for Bipolar Disorder (BD).
  • Pediatric Bipolar Disorder (PBD) may have stronger genetic links, making attention deficits in PBD crucial for validating BD endophenotypes.
  • Existing research shows uncertainty regarding the extent of attention deficits in PBD, particularly concerning the influence of Attention Deficit Hyperactivity Disorder (ADHD).

Purpose of the Study:

  • To investigate attention deficits in a sample of euthymic Pediatric Bipolar Disorder (PBD) patients who do not have comorbid conditions.
  • To assess the impact of working memory (WM) on attention task performance.
  • To determine if attention deficits in PBD are linked to mood symptoms, medication, or illness characteristics.

Main Methods:

  • Compared 30 remitted, comorbidity-free PBD patients (aged <17) with 30 matched controls on attention tasks.
  • Assessed working memory (WM) to control for potential confounding effects.
  • Analyzed attention performance data, controlling for age, sex, handedness, and Full-Scale IQ.

Main Results:

  • PBD patients exhibited poorer performance on multiple attention tasks compared to controls.
  • No significant differences in working memory (WM) performance were observed between PBD patients and controls.
  • Attention deficits in PBD were found to be independent of residual mood symptoms, medication, or specific illness characteristics.

Conclusions:

  • Attention deficits are confirmed in comorbidity-free PBD patients, reinforcing their status as an endophenotypic marker for bipolar disorder.
  • These findings demonstrate continuity in attention deficits between pediatric and adult bipolar disorder populations.
  • The study highlights the importance of assessing attention deficits in PBD, independent of ADHD, for understanding the disorder's genetic and neurobiological underpinnings.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
857
Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
677
Bipolar Junction Transistor01:22

Bipolar Junction Transistor

Bipolar Junction Transistors (BJTs) are essential elements in electronic circuits, playing a crucial role in the functionality of amplifiers, memories, and microprocessors. These transistors can be designed as NPN or PNP based on their doping patterns. They consist of three layers: the emitter, base, and collector. The configuration of these layers and their respective doping levels—with N-type or P-type impurities—define the transistor's type and its operational...
1.5K
Intrinsically Disordered Proteins02:18

Intrinsically Disordered Proteins

Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276